BioArctic AB: Clinical Trials

2 trials sponsored by BioArctic AB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow BioArctic AB: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy
exidavnemab, Placebo Comparator - Parkinson Disease, Multiple System Atrophy
Phase 2CompletedBioArctic AB382024-10-242026-08-21
Safety and Efficacy of SC0806 (Fibroblast Growth Factor 1 and a Device) in Traumatic Spinal Cord Injury Subjects
SC0806 and rehabilitation, Rehabilitation only - Spinal Cord Injury
Phase 1 / Phase 2CompletedBioArctic AB102015-06-012025-09-22

Conditions studied

Multiple System Atrophy (1)  ·  Parkinson Disease (1)  ·  Spinal Cord Injuries (1)

Interventions

Rehabilitation (1)

Countries

Poland (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Hans Basun, MD (1)